Cross-talk between the ATP and ADP nucleotide receptor signalling pathways in glioma C6 cells

Acta Biochimica Polonica

Volumn 49, Issue 4, 2002, Pages 877-889

  Czajkowski, Rafał ^a   Barańska, Jolanta ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Adenosine; Adenylyl cyclase; ADP; ATP; Cross talk; Glioma C6 cells; Nucleotide receptors; Phospholipase C; Signalling pathways

Indexed keywords

ANIMALIA;

EID: 0043155459     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2002_3747     Document Type: Review

References (52)

1. Abbracchio MP, Burnstock G. (1994) Purinoceptors: are these families of P2X and P2Y purinoceptors? Pharmacol Ther.; 64: 445-75.
2. Abbracchio MP, Burnstock G. (1998) Purinergic signalling: phatophysiological roles. Jpn J Pharmacol.; 78: 113-45.
3. 2+ entry. Cell Calcium.; 17: 207-15.
4. Barańska J, Przybylek K, Sabala P. (1999) Capacitative calcium entry. Glioma C6 as a model of nonexcitable cells. Pol J Pharmacol.; 50: 153-62.
5. Belardinelli L. (1993) Adenosine system in heart. Drug Dev Res.; 28: 263-7.
6. Berridge MJ. (1993) Inositol trisphosphate and calcium signalling. Nature.; 361: 315-25.
7. Berridge MJ. (1995) Capacitative calcium entry. Biochem J.; 312: 1-11.
8. Boarder MR, Hourani SM. (1998) The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol Sci.; 19: 99-107.
9. Bodin P, Burnstock G. (2001) Purinergic signalling: ATP release. Neurochem Res.; 26: 959-69.
10. Boeynaems JM, Communi D, Savi P, Herbert JM. (2000) P2Y receptors: in the middle of the road. Trends Pharmacol Sci.; 21: 1-3.
11. 1 purinergic receptor that inhibits adenylate cyclase. J Pharmacol Exp Ther.; 267: 1140-6.
12. Burnstock G. (1972) Purinergic nerves. Pharmacol Rev.; 24: 509-81.
13. Burnstock G. (1978) A basis for distinguishing two types of purinergic receptor. In Cell membrane receptors for drugs and hormones: a multidisciplinary approach. Straub RW, Bolis L. eds, pp 107-18. Raven Press, New York.
14. Chen W, Wieraszko A, Hogan MK, Yang H-A, Kornecki E, Ehrlich YH. (1996) Surface protein phosphorylation by ecto-protein kinase is required for the maintenance of hippocampal long-term potentiation. Proc Natl Acad Sci U S A.; 93: 8688-93.
15. 2+ entry exclusively inhibits cAMP synthesis in C6-2B glioma cells. J Biol Chem.; 270: 1149-55.
16. 1 adenosine receptors. Mol Pharmacol.; 52: 788-97.
17. 6 receptor. Biochem Biophys Res Commun.; 222: 303-8.
18. i. J Biol Chem.; 276: 41479-85.
19. Czajkowski R, Barańska J. (1999) Sphingosine and phorbol ester modulate protein kinase C activity and modify ATP-evoked calcium mobilization in glioma C6 cells. Biochem Biophys Res Commun.; 260: 614-8.
20. 12. FEBS Lett.; 513: 179-83.
21. Dubyak GR. (1991) Signal transduction by P2 purinergic receptors for extracellular ATP. Am J Resp Cell Mol Biol.; 4: 295-300.
22. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev.; 46: 143-56.
23. Fredholm BB, Abbracchio MP, Burnstok G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M. (1997) Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci.; 18: 79-82.
24. 2 receptor-mediated vasodepression does not involve a pertussis-toxin-sensitive G protein. Eur J Pharmacol.; 236: 255-62.
25. Grobben B, Anciaux K, Roymans D, Stefan C, Bollen M, Esmans EL, Siegers H. (1999) An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. J Neurochem.; 72: 826-34.
26. AC receptor activate MAP kinase by a ras-independent pathway in rat C6 glioma. J Neurochem.; 78: 1325-38.
27. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrshnan V, Van RB, Nurden A, Julius D, Conley PB. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature.; 409: 202-7.
28. Hur E-M, Kim K-T. (2002) G protein-coupled receptor signalling and cross-talk. Achieving rapidity and specificity. Cellular Signal.; 14: 397-405.
29. Illes P, Norenberg W. (1993) Neuronal ATP receptors and their mechanism of action. Trends Pharmacol Sci.; 14: 50-4.
30. 12 receptor. Br J Pharmacol.; 133: 521-8.
31. Khakh BS, Kennedy C. (1998) Adenosine and ATP: progress in their receptors structures and functions. Trends Pharmacol Sci.; 19: 39-41.
32. King FB, Townsend-Nicholson A, Burnstock G. (1998) Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharmacol Sci.; 19: 506-14.
33. Kitanaka J-I, Hashimoto H, Gotoh M, Mayum T, Baba A. (1992) Mechanism of extracellular ATP-stimulated phosphoinositide hydrolysis in rat glioma C6 cells. J Pharmacol Exp Ther.; 263: 1248-52.
34. 2A receptor-mediated modulation of striatal acetylcholine release in vivo. J Neurochem.; 66: 1882-8.
35. Lazarowski ER, Harden TK. (1994) Identification of a uridine nucleotide selective G protein-linked receptor that activates phospholipase C. J Biol Chem.; 269: 11830-6.
36. Lin W-W, Chuang D-M. (1993) Extracellular ATP stimulates inositol phospholipid turnover and calcium flux in C6 glioma cells. Neurochem Res.; 18: 681-7.
37. Nicholas R, Watt WC, Lazarowski ER, Li Q, Harden TK. (1996) Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective and an ATP and UTP-specific receptor. Mol Pharmacol.; 50: 224-9.
38. Pianet I, Merle M, Labouesse J. (1989) ADP and indirectly ATP are potent inhibitors of cAMP production in intact isoproterenol stimulated C6 glioma cells. Biochem Biophys Res Commun.; 163: 1150-7.
39. Putney JW Jr, Bird GStJ. (1993) The inositol phosphate-calcium signalling system in nonexcitable cells. Endocrine Rev.; 14: 610-31.
40. 2+ entry in human platelets. Evidence for conformational coupling. J Biol Chem.; 275: 7527-33.
41. 2+ signals induced by ATP and thapsigargin in glioma C6 cells. Neurochem Int.; 31: 55-64.
42. 2 are involved in calcium signalling in glioma C6 cells. Br J Pharmacol.; 132: 393-402.
43. Sabała P, Targos B, Caravelli A, Czajkowski R, Lim D, Gragnaniello G, Santella L, Barańska J. (2002) Role of the actin cytoskeleton in store-mediated calcium entry in glioma C6 cells. Biochem Biophys Res Commun.; 296: 484-91.
44. 12, a new platelet ADP receptor target of clopiogrel. Biochem Biophys Res Commun.; 283: 379-83.
45. 1-purinoceptor. Br J Pharmacol.; 118: 167-73.
46. 1 receptor to phospholipase C. Br J Pharmacol.; 122: 1021-24.
47. Selbie LA, Hill SJ. (1998) G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol Sci.; 19: 87-93.
48. Stiles GL. (1992) Adenosine receptors. J Biol Chem.; 267: 6451-54.
49. Webb TE, Feolde E, Vigne P, Neary JT, Runberg A, Frelin C, Barnard EA. (1996) The P2Y purinoceptor in rat brain microvascular endothelial cells coupled to inhibition of adenylate cyclase. Br J Pharmacol.; 119: 1385-92.
50. Windscheif U. (1996) Purinoceptors: from history to recent progress. A review. J Pharm Pharmacol.; 48: 993-1011.
51. I-coupled ADP receptor from human and mouse. J Pharmacol Exp Ther.; 301: 705-13.
52. Zimmermann M. (1994) Signalling via ATP in the nervous system. Trends Neurosci.; 17: 420-6.